Background/Aims: The counterbalance of macrophage migration inhibitory factor (MIF) and Gremlin-1 is a useful tool to predict the acuity of coronary artery disease (CAD) and plaque stability. Gremlin-1 is an endogenous antagonist of MIF and therefore influences plaque vulnerability. This study was designed to elucidate the mechanistic basis determining the biophysical binding of Gremlin-1 to MIF. Methods: An in silico model suggested that several charged C-terminal amino acids are crucial in mediating Gremlin-1/MIF-binding. We produced several single amino acid exchange mutants of Gremlin-1 by site-directed mutagenesis. These Gremlin-1 mutants were tested for their ability to reduce MIF effects on monocytes. Results: We observed that the critical element of the Gremlin-1 molecule for regulating MIF-induced chemotactic activity lies at the C-terminal region. A single amino acid exchange of an arginine to an alanine residue is sufficient to abolish the antagonistic effect of Gremlin-1 on MIF. Therefore, the Gremlin-1 mutant R172A failed to reduce MIF-induced monocyte differentiation into macrophages. Conclusion: Gremlin-1 C-terminus is essential for antagonizing MIF effects. Our results could offer a novel strategy utilizing Gremlin-1 to target pro-inflammatory effects of MIF in various diseases.
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Introduction
Gremlin-1 is a bone morphogenetic protein (BMP) antagonist and interacts with BMP-2, BMP-4 and BMP-7 [1] . Gremlin-1 plays an important role in embryogenesis and organ development via inhibition of BMP-mediated signaling pathways, especially in lungs, kidneys, heart, and the bone formation of body axis and limbs [2, 3] . The fact that the constitutive Gremlin-1 knockout mouse is neonatally lethal emphasizes its essential role during embryogenesis [4] . Gremlin-1 and its homologs are highly conserved glycoproteins throughout different species and belong to the cysteine knot superfamily, together with proteins like TGF-β and VEGF. Within this cysteine knot superfamily Gremlin-1 is classified as a member of DAN/Cerberus protein family and encodes a 23 kDa non-glycosylated form, which can also appear as a 28 kDa glycosylated form.
MIF (macrophage migration inhibitory factor) is a cytokine that has chemokine like functions. It directs the chemotaxis and recruitment of monocytes, their differentiation, substantiating their subsequent accumulation at atherosclerotic lesions [5, 6] . During the development of atherosclerotic plaques, monocyte recruitment and formation of macrophages are important events [7] . We showed previously that Gremlin-1 can act as an antagonist of MIF engaging in a high affinity binding with MIF as evidenced by surface plasmon resonance analysis [8] . We suggested the plasma Gremlin-1/MIF ratio as a predictive marker for classifying the severity of coronary artery disease (CAD) and to estimate plaque vulnerability [9] .
Materials and Methods

Generation of plasmids, PCR, primers
The pcDNA5FRT-TO plasmid for expression of wild type Gremlin-1 was synthesized by GeneArt AG (Regensburg, Germany). Gremlin-1 mutant plasmids were obtained by a site-directed mutagenesis kit (Agilent Technologies Sales & Services GmbH & Co. KG, Waldbronn, Germany) using the wild type Gremlin-1 plasmid as template. Primer pairs for mutagenesis are listed below and were purchased from Eurofins Genomic GmbH (Ebersberg, Germany). Mutagenesis PCR was performed according to the manufacturer's manual. Numbering of the amino acid residues was chosen according to the full length human wild type Gremlin-1 protein (UniProt ID: O60565).
Primer name Primer sequence 5'…. 3' K145A_fw GTC CTG CTC CTT CTG CGC GCC CAA GAA ATT CAC K145A_rev GTG AAT TTC TTG GGC GCG CAG AAG GAG CAG GAC K147A_fw GCT CCT TCT GCA AGC CCG CGA AAT TCA CTA CCA TG K147A_rev CAT GGT AGT GAA TTT CGC GGG CTT GCA GAA GGA GC R169A_fw CCC CAC CAA GAA AAA GGC CGT GAC CAG AGT GAA GCT TCA CTC T R169A_rev CTT CAC TCT GGT CAC GGC CTT TTT CTT GGT GGG G R172A_fw CAA GAA AAA GCG CGT GAC CGC TGT GAA GCA GTG CCG GTG CGC A R172A_rev GCA CCG GCA CTG CTT CAC AGC GGT CAC GCG CTT TTT CTT G
Cell isolation and cell lines
Human monocytes were isolated from peripheral venous blood samples by adherence depletion following differential centrifugation through a Ficoll-Paque gradient as described previously [10] . Flp-In TM -CHO cells were grown following the recommendations and instructions of the manufacturer (Invitrogen TM , Life Technologies GmbH, Darmstadt, Germany).
Protein production and purification
Protein production was performed in Flp-In TM -CHO cells after stable transfection as previously described [11] [12] [13] . As transfection reagent Lipofectamine2000 (Invitrogen TM , Life Technologies GmbH, Darmstadt, Germany) was used following the manufacturer's instructions. In brief, protein was produced by Flp-In TM -CHO cells for one week. Protein purification was performed by ProteinA-Agarose precipitation (Pierce TM Recombinant Protein A Agarose, Thermo Fisher Scientific, Life Technologies GmbH, Darmstadt, Germany). Protein concentrations were determined with anti-human IgG ELISA (Helvetica Healthcare, Switzerland) according to manufacturer's manual.
Monocyte chemotaxis
Migration of human monocytes was performed in RPMI1640 medium with stable glutamine supplemented with 10% FCS (fetal calf serum) and 1% penicillin/streptomycin (100 µg/ml each) using a 48-well-modified Boyden chamber (Neuro Probe Inc., Gaithersburg, USA) as described previously [11] equipped with a 5 µm polycarbonate filter membrane. In brief, the chemoattractant MIF (20 ng/ml) was preincubated with the wild type or mutant Gremlin-1 fusion protein, or control respectively, for 30 min at room temperature. Placing the MIF/Gremlin-1 mixture in the lower chamber, the monocytes were loaded onto the upper chamber and allowed to migrate at 37°C and 5% CO 2 for 4 hours. After migration the cells on the membrane filter were fixed in methanol and subsequently stained with May-Grünwald and Giemsa reagents.
In vitro model of macrophage and foam cell differentiation
Human monocytes were differentiated into macrophages/foam cells over 6 days. The effects of Gremlin-1 on formation of macrophages/foam cells were studied in vitro as described previously [14] [15] [16] . The formation of macrophages and foam cells was analyzed in the presence of MIF (20 ng/ml) by morphological assessment and CD14/CD68-staining with subsequent analysis by flow cytometry. CD14-APC antibody was purchased from R&D (R&D Systems, Inc., Minneapolis, USA), CD68-FITC antibody was purchased from Dako (Dako Deutschland GmbH, Hamburg, Germany). Before adding MIF to the monocytes, we preincubated 20 ng/ml MIF and 2 µg/ml wild type Gremlin-1, mutant Gremlin-1, or control respectively, for 30 min at room temperature in RPMI medium supplemented with 10% FCS and 1% penicillin/streptomycin (100 µg/ml each). After preincubation of the MIF/Gremlin-1 protein mixtures, human monocytes were cultured in the presence of these preincubated proteins at 5% CO2 and 37°C for 6 days.
Statistical Analysis
Data is presented as mean ± standard error of mean (SEM). Statistical significance was determined using one-way ANOVA with Tukey HSD (honestly significant difference) post hoc test and unpaired twotailed Student's t test where needed. For statistical analysis Prism 4 and 6 software for windows (version 4.03 and version 6.07, GraphPad Software, Inc.) was used. A p-value ≤ 0.05 was regarded as statistically significant.
Results
Generation of Gremlin-1 mutants and prediction of 3D-structure
In silico generated, mutated Gremlin-1 displays a significantly reduced binding to MIF in a computational docking simulation generated with Molegro Virtual Docker 5. The mutations are in the C-terminal region involving several positively charged amino acid residues (Fig.  1A) . The estimated dissociation constant of mutant Gremlin-1 is K D = 896 ± 36 nM compared to wild type Gremlin-1 with K D = 65 ± 6 nM and accordingly the predicted interaction energy between the mutated Gremlin-1 and MIF was higher than between wild type Gremlin-1 and MIF; precisely, mutated Gremlin-1/MIF -289.95 ± 31.47 kJ/mol vs. wild type Gremlin-1/ MIF -435.24 ± 26.35 kJ/mol (see table in Fig. 1A) . The mutated Gremlin-1 clearly showed a different surface charge distribution than the wild type Gremlin-1.
Based on this estimated area which seems important for MIF binding, 4 mutant constructs based on the wild type Gremlin-1-Fc plasmid were obtained by site-directed mutagenesis PCR, namely the single amino acid exchange mutants K145A, K147A, R169A and R172A (numbering is based on the wild type Gremlin-1 protein (UniProt ID: O60565)). The alignment of the C-terminal amino acid sequences of the 4 mutants as well as that of wild type Gremlin-1 is shown in Fig. 1B . Since there is no NMR structure of Gremlin-1 currently available we performed in silico modelling of wild type Gremlin-1 and the mutant R172A with I-TASSER (Iterative Threading ASSEmbly Refinement) (Fig. 1B) . This prediction suggests that the R172A-mutant could comprise a slightly altered three-dimensional folding compared to the wild type protein (Fig. 1B upper and middle panel) with a more bulky structure. The exact size and relative purity of the expressed wild type and mutant Gremlin-1 fusion proteins (schematic in Fig. 1C ) was proved via SDS-PAGE and subsequent Western Blot (Fig. 1D) .
Fc treated control cells to about 60% migrated monocytes (60.58 ± 6.40%, p < 0.0001) as observed in the MIF/wild type Gremlin-1 treated populations. Three of the tested Gremlin-1 mutants reduced MIF-induced monocyte migration comparable to wild type Gremlin-1, in particular the K145A (64.09 ± 5.14%), K147A (65.34 ± 6.03%), and R169A (50.49 ± 5.02%) mutants, respectively (Fig. 2A) . But one mutant, namely R172A, failed to reduce MIF-induced monocyte migration and interestingly showed significantly higher migration rates than Gremlin-1 treated populations (R172A/MIF 86.86 ± 6.82% vs. Gremlin-1/MIF 60.58 ± 6.40%, p = 0.0413). Preincubation of the Gremlin-1 mutant R172A with MIF showed no significant difference in the number of migrated monocytes as compared to the Fc/MIFpreincubated sets (86.86 ± 6.82% vs. 100%, p > 0.05).
R172A does not inhibit MIF-induced monocyte differentiation into macrophages and foam cells
Monocyte differentiation into macrophages and foam cells plays an important role in atherosclerosis [7, 8, 11, 16] . The MIF-induced monocyte differentiation into macrophages can be reduced by Gremlin-1 [11] , but presently could not be reduced by the Gremlin-1 mutant R172A (Fig. 2B-C) . Isolated human monocytes were differentiated into macrophages/foam cells over 6 days. Differentiation was induced by MIF (20 ng/ml) which was preincubated for 30 min with 2 µg/ml wild type Gremlin-1 or R172A fusion protein. During differentiation cell numbers were quantified on day 4 and day 6 (Fig. 2B) . Only wild type Gremlin-1, but not the R172A fusion protein, could reduce the MIF-induced differentiation of monocytes into macrophages and foam cells. On day 4 Gremlin-1 significantly reduced MIF-induced macrophage/foam cell formation from about 90% to 80% (MIF/Fc 88.93 ± 1.36% vs. MIF/ Gremlin-1 81.78 ± 1.18%, p = 0.0003), whereas mutant Gremlin-1 R172A was not able to reduce macrophage/foam cell differentiation and morphologically the cells looked like the Fc-treated cell populations (MIF/Fc 88.93 ± 1.36% vs. R172A 86.50 ± 1.08%, p > 0.05) (Fig. 2B, left panel) . Differentiation into macrophages/foam cells was also significantly reduced by wild type Gremlin-1 (MIF/Fc 68.07 ± 2.83% vs. MIF/Gremlin-1 57.62 ± 2.64%, p = 0.0185), on day 6, and not by mutant Gremlin-1 R172A (MIF/Fc 68.07 ± 2.83% vs. 68.27 ± 2.58%, p > 0.05) (Fig. 2B, right panel) . Mutant Gremlin-1 R172A was significantly less active in preventing MIF-induced monocyte differentiation, in particular MIF/R172A induced 86.50 ± 1.08% (day 4), or 68.27 ± 2.58% (day 6) macrophage/foam cell formation, compared to MIF/wild type Gremlin-1, which induced only 81.78 ± 1.18% (day 4), or 57.62 ± 2.64% (day 6) with a p-value of 0.0209 (day 4), or 0.0160 (day 6), respectively. On day 6 macrophage/foam cell development was analyzed by flow cytometry. We observed that consistent with the number of cells counted by morphologic features on day 6 (Fig. 2B) , MIF/wild type Gremlin-1-treated cells showed significantly less CD68-positive cells (136.0 ± 3.02%), compared to the MIF/Fc-treated population, which showed 168.2 ± 15.98% CD68-positive cells (Fig. 2C) . The Gremlin-1 mutant R172A on the other hand showed no significant reduction in CD68-positive cells, MIF/R172A-treated culture sets showed levels of CD68-positive cells comparable to the MIF/Fc-treated populations (MIF/R172 155.7 ± 6.81% vs. MIF/Fc 168.2 ± 15.98%, p > 0.05).
Discussion
MIF-dependent monocyte infiltration and macrophage formation are pivotal steps in atherosclerosis, plaque vulnerability and vascular inflammation [5] . Gremlin-1 reduces macrophage differentiation by antagonizing MIF, a cytokine critically involved in atherosclerotic plaque progression and vulnerability. Gremlin-1 binds to MIF with high affinity (K D = 54 nm), as proven by surface plasmon resonance analysis and coimmunoprecipitation, and reduces MIF-induced release of TNF-α from macrophages. Thus, Gremlin-1 acts as an endogenous antagonist of MIF and this defines a role for Gremlin-1/ MIF interaction in the context of atherosclerosis.
Previously, we demonstrated that recombinant fusion molecule, m Gremlin-1-Fc, binds with high affinity (K D = 76 nm) to MIF and substantially reduces the cellularity of atherosclerotic lesions in ApoE −/− mice, most prominently due to a decrease in macrophage infiltration [8] . In the present study we used in silico computer modelling to further characterize the binding activity of Gremlin-1 to the globular MIF protein. The computerbased analysis postulated that the C-terminal end of Gremlin-1 is critical for binding to MIF. In silico generated mutations of positively charged amino acid residues (arginine and lysine) within the C-terminus of Gremlin-1 substantially reduced the estimated binding affinity of Gremlin-1 for MIF in a computational docking prediction.
To further analyze the molecular mechanisms of Gremlin-1/MIF interaction we constructed various recombinant Gremlin-1 fusion proteins using site directed mutagenesis approach. We generated single amino acid exchange mutants of two C-terminal lysine residues (K145A and K147A), as well as of two arginine residues (R169A and R172A). We found that R172A, where the positively charged arginine residue was mutated to an uncharged alanine residue, showed a loss of activity to antagonize MIF-induced monocyte function. R172A could not attenuate MIF-triggered monocyte migration as validated using a modified Boyden-chamber migration assay. Interestingly we could also show that exchange of a nearby arginine residue (Arg169) with alanine showed no reduction of MIF-inhibiting function at all, indeed this R169A mutant rather showed a tendency to be even more active than wild type Gremlin-1 in the monocyte migration assay. Further, we analyzed the effect of this loss-of-function mutant in a monocyte differentiation assay as described previously [8, 16] . As documented previously, wild type Gremlin-1 but not the R172A mutant inhibited MIF-induced monocyte-derived macrophage/foam cell differentiation. This data suggests that the C-terminus of Gremlin-1 is critically involved in counteracting MIF.
In conclusion, our present data provides evidence that the C-terminus of Gremlin-1 plays an important role in regulation of MIF-induced monocyte functions and offers a novel strategy for development of pharmacological approaches to target MIF in various diseases including vascular inflammation and atherogenesis.
